Ace inhibitor spirapril effects on structural and functional vascular wall parameters in metabolic syndrome and essential arterial hypertension

Ace inhibitor spirapril effects on structural and functional vascular wall parameters in metabolic syndrome and essential arterial hypertension

Show other versions (1)

.

Bibliographic Details
Main Authors:	V. E. Oleynikov, I. B. Matrosova, Yu. A. Tomashevskaya, A. S. Gerasimova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2006-04-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1818

Similar Items

Ace inhibitor spirapril effects on structural and functional vascular wall parameters in metabolic syndrome and essential arterial hypertension
by: V. E. Oleynikov, et al.
Published: (2006-04-01)

Spirapril effectiveness and organo-protection in patients with metabolic syndrome and arterial hypertension
by: V. E. Oleynikov, et al.
Published: (2007-08-01)

Spirapril – a modern ACE inhibitor
by: V. M. Gorbunov
Published: (2005-06-01)

Comparative efficacy of ace inhibitor spirapril in hypertensive patients from various age groups
by: L. A. Sokolova, et al.
Published: (2006-06-01)

ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION
by: M. V. Leonova, et al.
Published: (2015-12-01)

ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION
by: M. V. Leonova, et al.
Published: (2015-12-01)

Spirapril therapy and its effects in arterial hypertension patients
by: M. V. Leonova, et al.
Published: (2006-02-01)

ACE inhibitor spirapril effects on circadian blood pressure profile, quality of life, and psychological status in patients with Stage I-II arterial hypertension
by: V. M. Gorbunov, et al.
Published: (2008-12-01)

Comparative effectiveness of ACE inhibitors spirapril, fosinopril, and enalapril in complex therapy of patients with coronary heart disease, chronic obstructive pulmonary disease, and arterial hypertension
by: M. A. Popova, et al.
Published: (2006-06-01)

Antihypertensive spirapril effectiveness in patients with mild to moderate arterial hypertension
by: M. M. Beraya, et al.
Published: (1970-01-01)

Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
by: M. M. Beraya, et al.
Published: (2007-02-01)

SPIRAPRIL EFFECTS ON OFFICE AND AMBULATORY BLOOD PRESSURE LEVELS AND THEIR DIFFERENCE IN PATIENTS WITH ARTERIAL HYPERTENSION
by: V. M. Gorbunov, et al.
Published: (2009-02-01)

ACE inhibitor trandolapril effectiveness in arterial hypertension
by: K. I. Tebloev, et al.
Published: (2008-04-01)

ACE inhibitors potential in correcting vessel wall anti-aggregation activity among patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2007-02-01)

ACE inhibitor zofenopril effectiveness in arterial hypertension treatment
by: D. A. Napalkov, et al.
Published: (2008-12-01)

The diagnostic value and clinical significance of a method for estimating the arterial stiffness BY cardio-ankle VASCULAR index
by: Valentin Elivich Oleynikov, et al.
Published: (2010-09-01)

ACE INHIBITORS IN ARTERIAL HYPERTENSION TREATMENT: FOCUS ON LISINOPRIL
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

ACE INHIBITORS IN ARTERIAL HYPERTENSION TREATMENT: FOCUS ON LISINOPRIL
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

ACE inhibitors and myocardial remodeling in patients with arterial hypertension and atrial fibrillation
by: O. N. Miller, et al.
Published: (2007-10-01)

SPIRAPRIL IN TREATMENT OF HEART FAILURE DUE TO DILATED CARDIOMYOPATHY
by: T. A. Abdullaev, et al.
Published: (2002-02-01)

ACE inhibitor effects of brachial artery structure and function in patients with arterial hypertension
by: L. V. Melnikova
Published: (2012-04-01)

ACE inhibitors in arterial hypertension treatment among various clinical groups
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

MECHANISMS OF COMBINED ACTION OF ACE INHIBITORS AND CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION
by: E. I. Astashkin, et al.
Published: (2013-06-01)

EFFECTIVENESS OF VASCULAR WALL ACTIVITY CORRECTION IN PATIENTS WITH ARTERIAL HYPERTENSION, METABOLIC SYNDROME, AND OCULO-VASCULAR OCCLUSION
by: I. N. Medvedev, et al.
Published: (2010-06-01)

Clinical and cost-effectiveness of ACE inhibitors in patients with arterial hypertension and coronary heart disease
by: O. Yu. Korennova, et al.
Published: (2008-08-01)

Effects of a fixed-dose combination of ACE inhibitor and nondihydropyridine calcium antagonist on endothelial dysfunction in patients with essential arterial hypertension
by: O. D. Ostroumova, et al.
Published: (2010-04-01)

Zofenopril (Zocardis) - cardioprotective ace inhibitor; clinical pharmacology and arterial hypertension treament experience
by: D. V. Preobrazhensky, et al.
Published: (2006-02-01)

CARVEDILOL EFFECTS ON INSULIN RESISTANCE AS A FACTOR DEFINING CLINICAL EFFECTIVENESS IN METABOLIC SYNDROME
by: V. E. Oleynikov, et al.
Published: (2009-04-01)

Effectiveness and safety of the ACE inhibitor and diuretic combination in postmenopausal women with arterial hypertension
by: G. G. Semenkova, et al.
Published: (2011-06-01)

Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
by: V. I. Makolkin
Published: (2008-12-01)

Clinical efficacy and vasoprotection of ACE inhibitors and beta3blockers in patients with arterial hypertension
by: Zh. N. Namsaraev, et al.
Published: (2004-02-01)

EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS
by: V. E. Oleynikov, et al.
Published: (2016-01-01)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015-12-01)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015-12-01)

The Vascular Wall State and Microcirculation Parameters in Patients with Controlled and Uncontrolled Arterial Hypertension
by: V. I. Podzolkov, et al.
Published: (2019-09-01)

ACE inhibitors in arterial hypertension management: zofenopril – class-specific effects and extra benefits
by: V. S. Zadionchenko, et al.
Published: (2007-04-01)

Combined therapy of arterial hypertension: focusing on a fixed-dose calcium antagonist/ACE inhibitor combination
by: D. V. Preobrazhensky, et al.
Published: (2008-08-01)

Long-term effects of ACE inhibitor on vascular remodelling
by: Tuleta Izabela, et al.
Published: (2014-12-01)

Arterial wall stiffness in patients with essential hypertension at young age
by: Kolesnik E.L.
Published: (2014-11-01)

Arterial hypertension treatment with a calcium channel blocker and an ACE inhibitor. Benefits of combination therapy
by: E. O. Taratukhin
Published: (2013-06-01)